Biogen Forges $278M MS Tie-Up With Alkermes
Biogen will receive an exclusive, worldwide license to commercialize ALKS 8700 and will pay Alkermes a mid-teens royalty on worldwide net sales of ALKS 8700. Source: BioSpace
Biogen will receive an exclusive, worldwide license to commercialize ALKS 8700 and will pay Alkermes a mid-teens royalty on worldwide net sales of ALKS 8700. Source: BioSpace
The financing will be used to push its Phase III clinical program of MDR-101 in living donor HLA-matched kidney transplant patients. Source: BioSpace
The agreement, whose final terms are still being negotiated, must be approved by a court. Source: BioSpace
Eli Lilly continues to make investments in its diabetes business. Source: BioSpace
Genentech is claiming that Pfizer's proposed biosimilar infringes 40 of its patents. Source: BioSpace
A number of biopharma companies are making strides in developing non-opioid pain killers or opioids that are more difficult to abuse. Source: BioSpace
Keith Speights, writing for The Motley Fool, notes one biotech that's booming. Source: BioSpace
The price of a single pill went up from 16p to 9.22 pounds, even though production costs remained broadly stable during that period, the CMA said. Source: BioSpace
HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace
Both Amazon and Rite Aid offered no comment for this story. Source: BioSpace